The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2020

Filed:

May. 08, 2017
Applicants:

Bayer Aktiengesellschaft, Leverkusen, DE;

Bayer Pharma Aktiengesellschaft, Berlin, DE;

Inventors:

Nicole Biber, Wuppertal, DE;

Damian Brockschnieder, Haan, DE;

Kersten Matthias Gericke, Wuppertal, DE;

Florian Kölling, Wuppertal, DE;

Klemens Lustig, Wuppertal, DE;

Jörg Meding, Wuppertal, DE;

Heinrich Meier, Wuppertal, DE;

Thomas Neubauer, Wuppertal, DE;

Martina Schäfer, Berlin, DE;

Andreas Timmermann, Düsseldorf, DE;

Dmitry Zubov, Remscheid, DE;

Carsten Terjung, Bochum, DE;

Niels Lindner, Wuppertal, DE;

Volker Badock, Berlin, DE;

Dieter Moosmayer, Berlin, DE;

Hideki Miyatake Ondozabal, Berlin, DE;

Stephen Moore, Sheffield, GB;

Alexander Schulz, Hannover, DE;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 31/506 (2006.01); C07D 471/04 (2006.01); A61K 31/4375 (2006.01); A61K 31/4709 (2006.01); A61K 31/497 (2006.01); C07D 519/00 (2006.01); A61K 45/06 (2006.01); A61K 31/444 (2006.01); A61P 11/00 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/4375 (2013.01); A61K 31/444 (2013.01); A61K 31/4709 (2013.01); A61K 31/497 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); A61P 11/00 (2018.01); A61P 29/00 (2018.01); C07D 471/04 (2013.01); C07D 519/00 (2013.01);
Abstract

The present application relates to novel substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-c][1,2,4]triazol-3-ones of formula (I), to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of lung inflammation disorders.


Find Patent Forward Citations

Loading…